<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 3, 2000
AVIGEN, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
<TABLE>
<S> <C>
0-28272 13-3647119
(Commission File No.) (IRS Employer Identification No.)
</TABLE>
1201 HARBOR BAY PARKWAY, SUITE 1000
ALAMEDA, CALIFORNIA 94502
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: (510) 748-7150
<PAGE> 2
ITEM 5. OTHER EVENTS.
Avigen made a public announcement in press release dated February 3, 2000, which
is attached hereto as Exhibit 99.1 and incorporated by reference herein.
ITEM 7. EXHIBITS.
<TABLE>
<S> <C>
99.1 Press Release, dated as of February 3, 2000 entitled "Avigen, Inc.
Announces Possible Public Offering."
</TABLE>
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
AVIGEN, INC.
Dated: February 3, 2000 By: /s/ Thomas J. Paulson
-----------------------------------
Thomas J. Paulson
Vice President, and
Chief Financial Officer
<PAGE> 4
INDEX TO EXHIBITS
<TABLE>
<S> <C>
99.1 Press Release, dated as of February 3, 2000 entitled "Avigen, Inc.
Announces Possible Public Offering."
</TABLE>
<PAGE> 1
EXHIBIT 99.1
COMPANY PRESS RELEASE
AVIGEN, INC. ANNOUNCES POSSIBLE PUBLIC OFFERING
ALAMEDA, Calif. -- Feb. 3, 2000 -- Avigen, Inc. (Nasdaq: AVGN) announced that it
is contemplating the filing of a registration statement with the Securities and
Exchange Commission for a public offering of its common stock. The timing and
size of the offering are dependent on market conditions and other factors.
This press release shall not constitute an offer to sell or the solicitation of
an offer to buy any securities of Avigen, Inc. The offering will be made only by
means of a prospectus contained in a registration statement to be filed with the
Securities and Exchange Commission, and will be sold through underwriters
engaged by the Company.
